Synergy CHC (SNYR)
Nasdaq Market Closed
Synergy CHC Corp. is a consumer health and wellness company that markets branded products across healthcare, beauty, nutrition, and lifestyle categories. Rather than operating as a single-product business, the company manages a portfolio of consumer-facing brands that are sold through multiple distribution channels, including retail, e-commerce, and other commercial partners.
One of Synergy CHC’s best-known brands is FOCUSfactor, a dietary supplement line positioned around memory, concentration, and cognitive support. The company’s portfolio has also included Flat Tummy, a women-focused wellness and lifestyle brand offering nutritional products associated with weight management and everyday health goals. Other brands referenced by the company include Hand MD and Neuragen, reflecting its broader interest in personal care and over-the-counter health-related consumer products.
Synergy CHC operates in markets where brand recognition, product formulation, marketing efficiency, and channel access are central to performance. The consumer health category includes vitamins, supplements, functional wellness products, topical treatments, and beauty-adjacent offerings, all of which can be influenced by changing consumer preferences and regulatory requirements around product claims and labeling.
The company’s strategy is based on building and distributing branded products rather than developing prescription medicines or medical devices. This gives it exposure to the fast-moving consumer products environment, where growth can depend on digital advertising, retail shelf space, repeat purchases, influencer and social media engagement, and the ability to maintain trust with health-conscious consumers. Investors typically assess Synergy CHC through the strength of its brands, sales momentum, margin profile, distribution relationships, and its ability to compete in crowded wellness and personal care categories.
Last updated
- Market Cap
- 3.58M
- P/E
- —
- P/FCF
- —
- P/S
- 0.13
- Enterprise Value
- 31.03M
- Sector
- Materials
- Industry
- Medicinal Chemicals and Botanical Products
- Address
- 865 SPRING STREET, WESTBROOK, ME, 04092
Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options
Alkane Resources Limited: Appointment of Non-Executive Director
Synergy CHC Corp. Announces Pricing of $4.375 Million Public Offering
Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 3.58M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 31.03M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- -0.14
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.13
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -2.86
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.12
- EPS
- -1.06
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 62.14%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -244.31%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- -1.09
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.91
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.42
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.04
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 4.94M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 0.24
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 5.49M | 6.07M | 8.01M | 8.13M | 8.17M |
| Gross profit | 3.97M | 2.22M | 5.68M | 6.24M | 6.16M |
| Operating income | -567.12K | -13.31M | 1.28M | 1.62M | 1.95M |
| EBITDA | -533.79K | -13.28M | 1.31M | 1.66M | 1.98M |
| Net income | -2.57M | -14.82M | 125.33K | 1.47M | 876.26K |
| Basic EPS | -0.23 | -1.54 | 0.01 | 0.17 | 0.1 |
| Diluted EPS | -0.23 | -1.54 | 0.01 | 0.17 | 0.1 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 6.46M | 10.16M | 20.69M | 19.73M | 15.66M |
| Total liabilities | 31.87M | 33.29M | 28.94M | 32.11M | 31.3M |
| Total equity | -25.41M | -23.13M | -8.25M | -12.38M | -15.64M |
| Cash & equivalents | 292.12K | 2.62M | 1.01M | 1.46M | 177.88K |
| Current assets | 6.24M | 9.91M | 20.41M | 19.41M | 15.31M |
| Current liabilities | 6.85M | 8.24M | 3.83M | 7.13M | 8.07M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -2.04M | 624.13K | -2.31M | -76.95K | -822.78K |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | -307.6K | 1.14M | 1.88M | 1.32M | 314.68K |
| Change in cash | -2.33M | 1.62M | -452.07K | 1.28M | -510.04K |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | EFFECT — Synergy CHC Corp. | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | S-1 — Synergy CHC Corp. | View Filing | |
| edgar index | 10-Q — Synergy CHC Corp. | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Synergy CHC Corp. | View Filing | |
| edgar index | 4 — Synergy CHC Corp. | View Filing | |
| form 4 | Form 4 — Kaushal Nitin | View Filing | |
| form 4 | Form 4 — Thompson Teresa Brigid | View Filing | |
| edgar index | PRE 14A — Synergy CHC Corp. | View Filing | |
| edgar index | S-8 — Synergy CHC Corp. | View Filing | |
| edgar index | NT 10-K — Synergy CHC Corp. | View Filing | |
| edgar index | 10-K — Synergy CHC Corp. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 424B5 — Synergy CHC Corp. | View Filing | |
| edgar index | EFFECT — Synergy CHC Corp. | View Filing | |
| edgar index | CORRESP — Synergy CHC Corp. | View Filing | |
| edgar index | S-3 — Synergy CHC Corp. | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| edgar index | 10-Q — Synergy CHC Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 3 — Synergy CHC Corp. | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| edgar index | 4 — Synergy CHC Corp. | View Filing | |
| edgar index | 4 — Synergy CHC Corp. | View Filing | |
| edgar index | 4 — Synergy CHC Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Baumeler Alfred | View Filing | |
| form 4 | Form 4 — Fickett Jaime | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 424B4 — Synergy CHC Corp. | View Filing | |
| edgar index | CORRESP — Synergy CHC Corp. | View Filing | |
| edgar index | CORRESP — Synergy CHC Corp. | View Filing | |
| edgar index | EFFECT — Synergy CHC Corp. | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | S-1 — Synergy CHC Corp. | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| edgar index | 10-Q — Synergy CHC Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Synergy CHC Corp. | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing | |
| edgar index | 8-K — Synergy CHC Corp. | View Filing | |
| form 4 | Form 4 — Ross Jack | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free